Skip to main content
main-content

Latest news

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Breaking headlines, in-depth features, hot topic review articles, and 

the latest from major international conferences brought to you by


Marked reduction in vascular events in diabetes patients after bariatric surgery

Obesity surgery

An observational study published in JAMA demonstrates a substantial reduction in the risk for hard cardiovascular endpoints in obese patients with type 2 diabetes who have undergone bariatric surgery.

EASE: Add-on empagliflozin improves glycemic control in type 1 diabetes

Pills

The addition of empagliflozin to insulin therapy reduces glycated hemoglobin levels in patients with type 1 diabetes, indicate findings from the phase III EASE-2 and 3 trials.

Latest headlines

10-17-2018 | Liraglutide (T2DM) | News

Cardiovascular benefits of liraglutide in type 2 diabetes apply to high-risk subgroups

The cardioprotective effects of liraglutide apply to patients with chronic kidney disease as well as those with established cardiovascular disease, show two post-hoc analyses of the LEADER trial.

10-16-2018 | Metabolic surgery | medwireNews | News

Marked reduction in vascular events in diabetes patients after bariatric surgery

An observational study published in JAMA demonstrates a substantial reduction in the risk for hard cardiovascular endpoints in obese patients with type 2 diabetes who have undergone bariatric surgery.

10-15-2018 | Genetics | News

SGLT1 haplotype linked to reduced cardiometabolic risk

Researchers have identified a haplotype of three missense mutations in the sodium-glucose cotransporter-1 gene that is associated with a reduced risk for impaired glucose tolerance, diabetes, and obesity.

medwireNews@EASD2018

The 2018 EASD Annual Meeting took place in Berlin from the 1st to 5th October. Click here for news and expert commentary, including the EASE, PREVIEW, and HARMONY trials.

Features and expert interviews

09-30-2018 | UKPDS | Feature | Article

The UKPDS: A lasting legacy

Twenty years after the publication of the primary findings, medwireNews talks to longtime UKPDS investigator Professor David Matthews (University of Oxford, UK) about the struggles of the team to bring the trial to completion and the impact of the findings on diabetes care.

03-27-2018 | Inpatient diabetes | Feature | Article

The inpatient diabetes audit: A tool for change

With the 2017 NaDIA results showing some positive trends in inpatient diabetes care, medwireNews talks to national clinical lead Gerry Rayman about the tools and tactics to deliver the best patient outcomes.

UK nutrition guidelines: A fresh approach

John Wilding talks to Pamela Dyson about the fresh approach taken to the latest update of the Diabetes UK nutrition guidelines.

image credits